SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Drugs informs about investment in equity shares of WOS

07 Mar 2026 Evaluate

Aarti Drugs has informed that the Finance & Investment Committee at its Meeting held on Saturday, March 7, 2026, approved the investment in equity shares of Pinnacle Life Science, wholly owned subsidiary (WOS) of the Company, upto an aggregate value of INR 10,00,00,000, by way of subscription to the Rights Issue. The details as required under SEBI Listing Regulations read with SEBI Mater Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed.

The above information is a part of company’s filings submitted to BSE.

Aarti Drugs Share Price

381.30 6.25 (1.67%)
05-Jun-2026 10:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1792.20
Dr. Reddys Lab 1271.95
Cipla 1390.50
Zydus Lifesciences 1092.05
Lupin 2279.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×